LitAlert ~~ GeneLit.com

    • Estimating the proportion of pathogenic variants from breast cancer case-control data: application to calibration of ACMG/AMP variant classification criteria.
    • James PA, Fortuno C, Li N, Lim BWX, Campbell IG, Spurdle AB.
    • Hum Mutat. 2022 Feb 22. doi: 10.1002/humu.24357. Epub ahead of print.
    • PARP inhibitors for metastatic castration-resistant prostate cancer: Biological rationale and current evidence.
    • Bienkowski M, Tomasik B, Braun M, Jassem J.
    • Cancer Treat Rev. 2022 Feb 11;104:102359. doi: 10.1016/j.ctrv.2022.102359. Epub ahead of print.
    • Review